MedTrace Logo

Characterizing the Cross-sectional Approach to Ovarian Cancer: Genetic Testing of BRCA

NCT03229122 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 446

Last updated 2019-06-10

No results posted yet for this study

Summary

The multi-centered, cross-sectional investigations shall be conducted in this study with the objective of identifying the ownership ratio of gBRCAm on the newly diagnosed patients with epithelial ovarian cancer, primary peritoneal cancer or fallopian tube cancer in Japan.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Toru Sugiyama, MD · Iwate Medical University

  • Daisuke Aoki, MD · Keio University

  • Takayuki Enomoto, MD. PhD. · School of Medicine, Niigata University

  • Nobuhiro Takeshima, MD. · The Cancer Institute Hospital Of JFCR.

  • Junzo Kigawa, MD, PhD · The Matsue City Hospital

  • Yo Watanabe · The Tohoku Medical and Pharmaceutical University

  • Masami Arai, MD. PhD. · The Cancer Institute Hospital Of JFCR.

Eligibility

Min Age
20 Years
Max Age
130 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-26
Primary Completion
2018-07-06
Completion
2018-07-06

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03229122 on ClinicalTrials.gov